Jump Financial’s Vaxcyte PCVX Stock Holding History

Jump Financial’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.85M	Buy	+135,000	New	+$7.33M	0.06%	340
2026 Q1	–	Sell	-89,822	Closed	-$4.14M	–	2286
2025 Q4	$4.14M	Sell	89,822 -101,878	-53%	-$4.56M	0.05%	414
2025 Q3	$6.91M	Sell	191,700 -211,897	-53%	-$7.02M	0.08%	311
2025 Q2	$13.1M	Buy	403,597 +303,497	+303%	+$9.95M	0.14%	176
2025 Q1	$3.78M	Buy	+100,100	New	+$8M	0.05%	402
2024 Q4	–	Sell	-51,516	Closed	-$5.89M	–	1915
2024 Q3	$5.89M	Buy	+51,516	New	+$4.64M	0.12%	186
2024 Q2	–	Sell	-30,224	Closed	-$2.06M	–	2144
2024 Q1	$2.06M	Buy	+30,224	New	+$2.09M	0.06%	429
2023 Q2	–	Sell	-105,800	Closed	-$3.97M	–	2070
2023 Q1	$3.97M	Buy	105,800 +54,158	+105%	+$2.3M	0.16%	199
2022 Q4	$2.48M	Buy	+51,642	New	+$2.03M	0.13%	208
2021 Q1	–	Sell	-8,100	Closed	-$215K	–	1199
2020 Q4	$215K	Buy	+8,100	New	+$301K	0.04%	748

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Jump Financial's PCVX Position: Q2 2026 in Review

Jump Financial opened a new position in Vaxcyte (PCVX) in Q2 2026: 135,000 shares worth $7.85M. The stake represents 0.06% of the portfolio and ranks #340 among its holdings. This is a return to the name: Jump Financial previously reported a position in PCVX as recently as Q4 2025.

Jump Financial first reported a position in PCVX in Q4 2020 and has held it in 10 quarters since. The position peaked at $13.1M in Q2 2025. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

Jump Financial held 135,000 shares of Vaxcyte worth $7.85M as of Q2 2026.
Vaxcyte was a new Jump Financial position in Q2 2026.
Vaxcyte made up 0.06% of Jump Financial's portfolio in Q2 2026, its #340 holding.
Jump Financial first reported a position in Vaxcyte in Q4 2020 and has held it in 10 quarters since.
Jump Financial's Vaxcyte position peaked at $13.1M in Q2 2025.
331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.